Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients
Clinical trial NCT04762628 · COMPLETED
Trial details
- NCT number
- NCT04762628
- Sponsor
- Saisei Pharma
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2021-07-05
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.